Poseida Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.377; its P/E ratio is -1.76; Poseida Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 25.00M	$ 9.35M	$ 20.01M	$ 10.34M	$ 10.05M
Gross Profit	$ 25.00M	$ 9.35M	$ 20.01M	$ 10.34M	$ 10.05M
EBIT	$ -23.08M	$ -29.43M	$ -25.32M	$ -36.82M	$ -31.05M
EBITDA	$ -23.62M	-	$ -25.83M	$ -37.48M	$ -33.75M
Net Income Common Stockholders	$ -25.35M	$ -31.78M	$ -27.46M	$ -38.85M	$ -33.32M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 212.20M	$ 238.84M	$ 214.61M	$ 247.20M	$ 282.49M
Total Assets	$ 273.88M	$ 302.25M	$ 281.21M	$ 313.62M	$ 351.84M
Total Debt	$ 85.42M	$ 86.26M	$ 87.08M	$ 87.89M	$ 88.75M
Net Debt	$ -126.78M	$ -152.58M	$ -127.53M	$ -159.31M	$ -193.74M
Total Liabilities	$ 170.18M	$ 178.59M	$ 145.91M	$ 156.06M	$ 164.24M
Stockholders Equity	$ 103.70M	$ 123.66M	$ 135.26M	$ 157.56M	$ 187.59M
Cash Flow	-
Free Cash Flow	$ -29.11M	-	$ -34.50M	$ -38.81M	$ 2.14M
Operating Cash Flow	$ -28.80M	$ 7.90M	$ -33.32M	$ -38.03M	$ 2.40M
Investing Cash Flow	$ 47.71M	$ -47.24M	$ 43.07M	$ -4.42M	$ -85.89M
Financing Cash Flow	-	$ 14.94M	-	$ 1.19M	$ 58.00K

Currency in USD

Poseida Therapeutics Earnings and Revenue History

Income Statement >

Poseida Therapeutics Debt to Assets

Balance Sheet >

Poseida Therapeutics Cash Flow

Cash Flow >

Poseida Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing